One of Orange County’s fastest-growing public companies only went public two months ago. Beta Bionics Inc.’s concept of an artificial pancreas that regulates blood sugar levels in people with type 1 diabetes (T1D) was well received by Wall Street. It raised an upsized $234.6 million during its January debut, $120 Read More
Tarsus Pharmaceuticals Inc. closed an upsized $134.8 million public offering this month. The Irvine-based biopharmaceutical company plans to use net proceeds to boost commercialization of its eyedrop Xdemvy in the U.S., as well as develop treatments for other diseases such as ocular rosacea and Lyme disease, according to a Feb. Read More
Aeon Biopharma Inc. has announced that Marc Forth is stepping down as chief executive and president, effective April 4. The Irvine-based biopharmaceutical company appointed Jost Fischer, current chairman of the board, as interim CEO. “On behalf of the Board, I want to thank Marc for his invaluable contributions to AEON Read More
Orthopaedic Specialty Institute yesterday announced that it’s merging with several practice groups to become “the largest independent orthopedic and neurosurgery provider in Southern California.” The Orange-based independent orthopedic medical group said it has launched a new division focused on neurosurgery. “We are excited to announce this merger, which positions OSI Read More
